Louis E. Nelson, MD, M. Catherine Slusher, MD, Ami H. Keatts, MD, LeDene King, MD, Michael J. Botticelli, MD, Receive InTone Specialist Certification
InControl Medical has certified Louis E. Nelson, MD, M. Catherine Slusher, MD, , Ami H. Keatts, MD, LeDene King, MD, Michael J. Botticelli, MD, and Neil J. Correia, MD, to prescribe InTone for women with bladder leakage.
Harrisonburg, Virginia (PRWEB) July 23, 2013
InTone, developed by InControl Medical, LLC, is a medical device available by prescription, indicated for the treatment of stress incontinence, urge incontinence or mixed (stress and urge) incontinence. Available by prescription, InTone combines a daily program of volitional exercises, voice-guided instruction, biofeedback and micro-current stimulation to strengthen muscle tone in the pelvic floor.
Stress incontinence can occur when lifting, sneezing, coughing, laughing or exercising. Urge incontinence is the unwanted and sudden need to urinate. Both can be caused or exacerbated by childbirth, obesity, excessive exercise, lack of exercise, age or trauma.
According to the National Association for Continence, up to 30 million women in America have experienced bladder leakage issues. About one in four new mothers experience “leaking” following normal delivery, and about one in six following cesarean section.
Up to two-thirds of women who “leak” have never mentioned it to their physicians, and up to two-thirds of women do not use any treatment or product to manage their bladder leakage.
Until now, available options had mixed results. Absorbent pads and diapers do nothing to treat the condition. Medications, if prescribed, can cause side effects and are not always effective. Surgery, if performed, is a more invasive option, and is not always effective. Research has shown that even when properly taught how to perform pelvic floor, or Kegel, exercises, about half of all women do them incorrectly.
When asked about treating incontinence M. Catherine Slusher, MD, stated “This well-known treatment, previously unachievable due to inconvenience, cost, and inability to continue long-term, is now available for practice and demonstrates efficacy in controlling unwanted incontinence. It is convenient and can be carried out in the privacy of the patient’s home with excellent long-term and continuing benefits."
After prescribing InTone, the physician customizes the settings for InTone and the patient is shown how to use it at home. A sensor in the unit measures pressure to determine if the patient is doing the exercises properly. The biofeedback unit uses voice-guided instruction to take her through the routine and reports her muscle isolation and strength. Each daily session takes about ten minutes, and data from each session is recorded. After two weeks or so, the physician analyzes the recorded data and adjusts InTone based on the patient’s progress, and at-home treatment sessions continue. Most patients should experience progress in a few weeks, and most patients should experience effective relief in 90 days.
InTone is available by prescription to patients in the United States. InTone was developed by InControl Medical, LLC, based in Brookfield, Wisconsin. InControl Medical provides specialty medical products for women’s health, and is sourced and manufactured entirely in the United States. More information on InTone can be found at http://www.incontrolmedical.com.
To contact Louis E. Nelson, MD, M. Catherine Slusher, MD, , Ami H. Keatts, MD, LeDene King, MD, Michael J. Botticelli, MD, and Neil J. Correia, MD, please call (757) 874-2229.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10952473.htm